TY - JOUR
T1 - Associations between antipsychotics-induced weight gain and brain networks of impulsivity
AU - Grosu, Claire
AU - Klauser, Paul
AU - Dwir, Daniella
AU - Khadimallah, Ines
AU - Alemán-Gómez, Yasser
AU - Laaboub, Nermine
AU - Piras, Marianna
AU - Fournier, Margot
AU - Preisig, Martin
AU - Conus, Philippe
AU - Draganski, Bogdan
AU - Eap, Chin B.
N1 - Funding Information:
This work has been funded in part by the Swiss National Research Foundation (CBE and PC: 320030–120686, 324730–144064, 320030–173211; 320030–200602). PK was supported by the Adrian & Simone Frutiger Foundation. DD is supported by the Adrian & Simone Frutiger Foundation. The CoLaus|PsyCoLaus study was supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, the Swiss National Science Foundation (grants 3200B0–105993, 3200B0–118308, 33CSCO-122661, 33CS30–139468, 33CS30–148401, 33CS30_177535 and 3247730_204523) and the Swiss Personalized Health Network (project: Swiss Ageing Citizen Reference). BD is supported by the Swiss National Science Foundation (project grants Nr. 32003B_212466, 324730_192755 and CRSII5–3_209510), ERA_NET iSEE project (32NE30_198552), the Swiss Personalised Health Network SACR project, the CLIMACT starting grant UNIL-EPFL, and the Leenaards Foundation. LREN is very grateful to the Roger De Spoelberch and Partridge Foundations for their generous financial support.
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/3/26
Y1 - 2024/3/26
N2 - Given the unpredictable rapid onset and ubiquitous consequences of weight gain induced by antipsychotics, there is a pressing need to get insights into the underlying processes at the brain system level that will allow stratification of “at risk” patients. The pathophysiological hypothesis at hand is focused on brain networks governing impulsivity that are modulated by neuro-inflammatory processes. To this aim, we investigated brain anatomy and functional connectivity in patients with early psychosis (median age: 23 years, IQR = 21–27) using anthropometric data and magnetic resonance imaging acquired one month to one year after initiation of AP medication. Our analyses included 19 patients with high and rapid weight gain (i.e., ≥5% from baseline weight after one month) and 23 patients with low weight gain (i.e., <5% from baseline weight after one month). We replicated our analyses in young (26 years, IQR = 22–33, N = 102) and middle-aged (56 years, IQR = 51–62, N = 875) healthy individuals from the general population. In early psychosis patients, higher weight gain was associated with poor impulse control score (β = 1.35; P = 0.03). Here, the observed brain differences comprised nodes of impulsivity networks - reduced frontal lobe grey matter volume (Pcorrected = 0.007) and higher striatal volume (Pcorrected = 0.048) paralleled by disruption of fronto-striatal functional connectivity (R = −0.32; P = 0.04). Weight gain was associated with the inflammatory biomarker plasminogen activator inhibitor-1 (β = 4.9, P = 0.002). There was no significant association between increased BMI or weight gain and brain anatomy characteristics in both cohorts of young and middle-aged healthy individuals. Our findings support the notion of weight gain in treated psychotic patients associated with poor impulse control, impulsivity-related brain networks and chronic inflammation.
AB - Given the unpredictable rapid onset and ubiquitous consequences of weight gain induced by antipsychotics, there is a pressing need to get insights into the underlying processes at the brain system level that will allow stratification of “at risk” patients. The pathophysiological hypothesis at hand is focused on brain networks governing impulsivity that are modulated by neuro-inflammatory processes. To this aim, we investigated brain anatomy and functional connectivity in patients with early psychosis (median age: 23 years, IQR = 21–27) using anthropometric data and magnetic resonance imaging acquired one month to one year after initiation of AP medication. Our analyses included 19 patients with high and rapid weight gain (i.e., ≥5% from baseline weight after one month) and 23 patients with low weight gain (i.e., <5% from baseline weight after one month). We replicated our analyses in young (26 years, IQR = 22–33, N = 102) and middle-aged (56 years, IQR = 51–62, N = 875) healthy individuals from the general population. In early psychosis patients, higher weight gain was associated with poor impulse control score (β = 1.35; P = 0.03). Here, the observed brain differences comprised nodes of impulsivity networks - reduced frontal lobe grey matter volume (Pcorrected = 0.007) and higher striatal volume (Pcorrected = 0.048) paralleled by disruption of fronto-striatal functional connectivity (R = −0.32; P = 0.04). Weight gain was associated with the inflammatory biomarker plasminogen activator inhibitor-1 (β = 4.9, P = 0.002). There was no significant association between increased BMI or weight gain and brain anatomy characteristics in both cohorts of young and middle-aged healthy individuals. Our findings support the notion of weight gain in treated psychotic patients associated with poor impulse control, impulsivity-related brain networks and chronic inflammation.
UR - https://www.scopus.com/pages/publications/85188565079
U2 - 10.1038/s41398-024-02881-4
DO - 10.1038/s41398-024-02881-4
M3 - Article
C2 - 38531873
AN - SCOPUS:85188565079
SN - 2158-3188
VL - 14
JO - Translational Psychiatry
JF - Translational Psychiatry
IS - 1
M1 - 162
ER -